company background image
000518 logo

Jiangsu Sihuan Bioengineering XSEC:000518 Stock Report

Last Price

CN¥3.06

Market Cap

CN¥3.2b

7D

-11.3%

1Y

-6.1%

Updated

23 Dec, 2024

Data

Company Financials

Jiangsu Sihuan Bioengineering Co., Ltd

XSEC:000518 Stock Report

Market Cap: CN¥3.2b

000518 Stock Overview

Engages in the pharmaceutical business in China. More details

000518 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Jiangsu Sihuan Bioengineering Co., Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Jiangsu Sihuan Bioengineering
Historical stock prices
Current Share PriceCN¥3.06
52 Week HighCN¥3.99
52 Week LowCN¥1.72
Beta0.42
1 Month Change-9.20%
3 Month Change50.00%
1 Year Change-6.14%
3 Year Change-15.24%
5 Year Change-7.27%
Change since IPO-63.40%

Recent News & Updates

Recent updates

Shareholder Returns

000518CN BiotechsCN Market
7D-11.3%-1.9%-1.2%
1Y-6.1%-16.2%11.8%

Return vs Industry: 000518 exceeded the CN Biotechs industry which returned -16.2% over the past year.

Return vs Market: 000518 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 000518's price volatile compared to industry and market?
000518 volatility
000518 Average Weekly Movement11.4%
Biotechs Industry Average Movement8.8%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 000518's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 000518's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
1992282Yu Guowww.000518shsw.com/shsw

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusen, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass; Xinde Lusheng; Xin Lisheng; and Ring BO. It also engages in breeding and sales of flowers and seedlings; and landscaping projects.

Jiangsu Sihuan Bioengineering Co., Ltd Fundamentals Summary

How do Jiangsu Sihuan Bioengineering's earnings and revenue compare to its market cap?
000518 fundamental statistics
Market capCN¥3.15b
Earnings (TTM)-CN¥46.57m
Revenue (TTM)CN¥211.48m

14.9x

P/S Ratio

-67.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000518 income statement (TTM)
RevenueCN¥211.48m
Cost of RevenueCN¥84.47m
Gross ProfitCN¥127.01m
Other ExpensesCN¥173.58m
Earnings-CN¥46.57m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.045
Gross Margin60.06%
Net Profit Margin-22.02%
Debt/Equity Ratio3.1%

How did 000518 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 17:32
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jiangsu Sihuan Bioengineering Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution